ophiochepalus striatus extract

Botanicalexperimental

Clinical trial activity

5 trials · 9 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
3
Phase 4
1

Earliest trial started Mar 1, 2008 (NCT00817024)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2017

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • fructus schizandrae - radix ginseng - radix ophiopogonis
  • fructus schizandrae, radix ginseng, radix ophiopogonis drug combination
  • ophiochepalus striatus extract
  • sheng mai
  • shengmaisan
  • sheng-mai-san
  • sheng-mai-yin
  • shenmai
  • shenmai
  • shen mai

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05869383Phase 2/Phase 3 (Phase 3)May 1, 2023Universitas Sriwijaya
NCT03185923Phase 3Jun 20, 2017Henan University of Traditional Chinese Medicine
NCT03065595Phase 4Oct 5, 2016University of Indonesia
NCT02583802Phase 2/Phase 3 (Phase 3)Sep 1, 2013Beijing First Hospital of integrated Chinese and Western Medicine, Chinese Ministry of Education, Peking University, Taipei Medical University
NCT00817024N/AMar 1, 2008Capital Medical University, China Academy of Chinese Medical Sciences
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (9)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Beijing First Hospital of integrated Chinese and Western MedicineAcademic/Hospital1012013
Capital Medical UniversityAcademic/Hospital1012008
China Academy of Chinese Medical SciencesAcademic/Hospital1112008
Chinese Ministry of EducationGovernment1012013
Henan University of Traditional Chinese MedicineAcademic/Hospital1112017
Peking UniversityAcademic/Hospital1112013
Taipei Medical UniversityAcademic/Hospital1012013
Universitas SriwijayaAcademic/Hospital1112023
University of IndonesiaAcademic/Hospital1112016
9 organizations
Page 1 / 1